Material para

You might also like

Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 89

MATERIAL PARA

PRÁTICA DE TRADUÇÃO

Neuro - Oncology
The program offers a
consulting service that
includes evaluation,
discussion, and a second
opinion. In what are
called Integrated Clinics,
which are in the Morumbi
Unit, the service is
performed simultaneously
by a team composed of a
clinical oncologist, a neuro-
oncologist, a neurosurgeon,
a radiotherapist and a
nurse, based on the prior
review of the imaging and
pathology by a neuro-
radiologist and a neuro-
pathologist. Every
Thursday at noon there are
also multidisciplinary
meetings - Tumor Boards -
for discussion of cases with
tumors of the nervous
system.
Center of Excellence in
Memory (NEMO)
The NEMO has a team of
highly specialized
professionals who use high
technology techniques to
reach the earliest possible
diagnosis of the disease and
the appropriate treatment
to ensure a better quality of
life for patients and their
families. This Center
provides a second opinion
service with a specialized
neurologist in the Morumbi
Unit.
Multiple Sclerosis
In the Multiple Sclerosis
Center at the Hospital
Israelita Albert Einstein,
the patients receive
complete care including
diagnosis, treatment, and
daily monitoring. The care
includes, among other
things, recommendation
for auxiliary therapy, a
second opinion service for
physicians regarding
treatment, the early
identification of any
therapeutic failure,
identification of adverse
effects, and improved
patient adherence to the
recommended treatment,
in addition to early
identification of possible
serious complications
arising from
immunosuppressant
treatments.  
Quality Certificates -
Neurology
Stroke is the leading cause
of disability in this country,
and our Sstroke Center
was the first center in Latin
America to have a specific
certification from the Joint
Commission International
(JCI), the most respected
certifier of quality in
medicine in the world. 

Hospital Israelita Albert


Einstein was the first
hospital in Latin America
to receive the JCI
certification for its services.
Since 1999, Einstein is the
only hospital in Brazil to
have earned that
certification four times in a
row.
This certification is proof
of Einstein’s commitment
to excellence in health,
reflected also in the
forefront of clinical and
experimental research such
as our development of new
protocols on
neuroprotective drugs, by
means of a
multidisciplinary program
in neuroscience, in
collaboration with the
Weizmann Institute of
Israel. 
The implementation of an
advanced protocol based
on scientific evidence , has
significantly reduced the
rate of mortality and
disability in patients with
Stroke..

Our knowledge about the


treatment of stroke has
been shared with more
than 400 doctors, nurses,
and health professionals
from the Hospital
Municipal de Campo
Limpo (in the south zone of
São Paulo City), and from
the Mobile Emergency
Care Service (SAMU). 

More than excellence in


health care, our mission is
the respect for life,
commitment to high
standards of science and
technology, and the sharing
of knowledge with society.

Stroke (CVA) Protocol


Wishing to promote an
agile, comprehensive,
integrated, and organized
customer service, the
Einstein reformulated its
care in Neurology and, in
September of 2004, created
the Einstein Neurology
Program – Stroke.
Wishing to promote an
agile, comprehensive,
integrated, and organized
service, Einstein
reformulated its care in
Neurology and, in
September of 2004, created
the Einstein Neurology
Program – Stroke.

Integrated Care and Focus


on the Patient
Stroke is one of the leading
causes of death and
neurological sequelae in the
modern world.

The main goal of Einstein


Neurology Program -
Stroke is to offer an agile
service that, through the
work of the
multiprofessional team,
seeks the best clinical
outcomes for the patient,
with shorter hospital stay,
and provides a better
quality of life. For this
reason, a treatment
protocol was established
for patients suspected of
having a stroke. The team
remains available 24 hours
a day for immediate
diagnosis and treatment.

Prompt Intervention
One of the critical factors
for patients who show signs
and/or symptoms of a
stroke is the promptness of
care. The quicker the
intervention, the greater
the chances of the patient
evolving without sequelae
and , having a shorter
hospital stay. One of the
indicators of Einstein
Neurology Program –
Stroke is the time between
arriving at the Emergency
Care Unit (UPA) and doing
a tomography, when
recommended.

The world's best practices


establish that this indicator
should be less than 45
minutes ( from door do CT
interpretation). Since
August of 2005, all treated
cases have reached this
goal and the time has
continued to decrease since
then.

This entire process is


supported by a cutting-
edge infrastructure.
Another important
distinction of the program
is the presence of
neurologists in the UPA, 24
hours a day, every day of
the week.
Open 24 Hours
Einstein Neurology
Program – Stroke has an
intensive neurological unit,
a step-down neurological
unit, and a neurological
hospitalization unit and all
of these have teams
specialized in the treatment
of stroke patients.

Immediate Diagnosis
For a patients with signs
and/or symptoms of stroke,
time and diagnostic quality
are fundamental to the
establishment of
appropriate treatment.
Einstein Neurology
Program – Stroke offers
state-of-the-art equipment
and a specialized team in
neuroradiology: magnetic
resonance imaging with
diffusion and perfusion,
echocardiograms,
angiotomography,
ultrasound, and it also has
interventional
neuroradiologists. Through
the implementation of a
structured report and of a
standardized way of
looking at the tests, it is
possible to maintain speed
and accuracy of diagnosis
with maximum quality.

Rehabilitation for Stroke


Patients 
The sooner the
rehabilitation of the patient
with stroke begins, the
better and faster will be
his/her recovery and,
consequently, the shorter
the hospitalization time.
The program has the
support of professionals
specialized in the recovery
of stroke patients through
training and adaptation to
daily life activities, in the
recovery of speech and,
especially, in the detection
and treatment of dysphagia
(difficulty in swallowing),
that increases the risk of
aspiration and pneumonia.

Stroke Center 
Contact: 2151-1301
Hours: Monday through
Friday: from 8 AM to 6
PM
For emergencies: 2151-
1301
CALL CENTER
55 11 2151-1233
CONTACT US
Send us your comments
and suggestions

Stroke/Cerebrovascular
accident (CVA)
Stroke (CVA) is a medical
emergency and can be
effectively treated if the
patient is quickly routed to
an appropriate hospital.  
Early recognition of signs
and symptoms, a rapid
neurological evaluation,
and an imaging
examination (tomography
or magnetic resonance
imaging) are essential for
survival. After the imaging
exam it is possible to
determine whether the
patient has had an ischemic
or hemorrhagic stroke.
The treatment of ischemic
stroke, used around the
world for many years, can
be done with a
thrombolytic agent
administered into the
patient’s vein. The function
of the drug is to dissolve
the blood clot that is
clogging the intra-cerebral
artery and causing
ischemia. Ideally the
deadline for beginning the
drug treatment is four and
a half hours after the first
symptoms.  

Control 
Treating a hemorrhagic
stroke is more complex and
requires the patient to be
admitted into a critical
care unit with neurological
monitoring capacity. In
such a specialized unit, it is
possible to properly control
blood pressure and any
alterations seen during the
neurological exam. In some
cases, neurosurgery may be
needed, which demands
agility from the hospital to
get a rapid assessment
from the neurosurgeon. 

Both ischemic and


hemorrhagic strokes
require a strict control of
blood glucose levels (blood
sugar) and the prevention
of fever. Medications may
be necessary to reach a
balance of the functions
desired.

Some auxiliary tests can


help identify the cause of
the stroke sooner. The most
common tests are
electrocardiogram,
echocardiogram, Doppler
ultrasound of the carotid
arteries, transcranial
Doppler ultrasound, and
laboratory tests. Such tests
are commonly performed
during the first 48 hours
after an ischemic stroke.
CALL CENTER
55 11 2151-1233
CONTACT US
Send us your comments
and suggestions
SOCIAL MEDIA

Parkinson's disease and


other movement disorders
Parkinson's disease causes
a chronic and progressive
degeneration of the central
nervous system, causing
the patient to lose motor
control. It is caused by
reduced dopamine
production, which is what
normally helps in making
voluntary bodily
movements. Without this
substance, the muscles
cease to respond
automatically to commands
from the brain. The main
symptoms of the disease
are tremors, rigidity, and
slowness of movements.
The disease may also lead
the patient to fall
frequently and to have
difficulty in performing
daily activities like
drinking water or walking.

Center of Deep Brain


Stimulation for
Parkinson's Disease 
Hospital Israelita Albert
Einstein has a group
specialized in the treatment
of this disease, which
operates in the Center of
Deep Brain Stimulation for
Parkinson's disease. In
addition to a set of
medications, the treatment
may include Deep Brain
Stimulation, a procedure
performed by the hospital. 

This procedure, known as


DBS, consists in implanting
a kind of pacemaker in the
brain. Similar to the device
used in cardiac surgery, the
technique provides
immediate relief to the
patient via a high
frequency electrical
stimulation in the brain. 
Its main benefits are:
improving quality of life,
decreasing the impact of
the disease and medication,
prolonging the effect of the
medication, and reducing
the main symptoms of the
disease such as tremors,
rigidity, and the excess of
involuntary movements.

Patients who do not have a


surgical recommendation
for the DBS will benefit
from consulting with a
physiatrist who can
establish a rehabilitation
plan to promote a better
quality of life with the help
of the multiprofessional
team.

Neuro-Oncology
Neuro-Oncology at the
Hospital Israelita Albert
Einstein offers an excellent
infrastructure for
diagnosing and treating
patients with tumors of the
nervous system, with a
highly specialized medical
staff and the latest
generation equipments. A
partnership with the MD
Anderson Cancer Center
(Houston, Texas), one of
the largest hospitals in the
world, specialized in the
treatment and research in
oncology, contributes to the
continuous improvement
and guarantees the
excellence of medical
services and care provided
to our patients.
The program offers a
consulting service that
includes assessment,
discussion, and second
opinion. In what are called
Integrated Clinics, located
at Morumbi Unit, the
service is performed
simultaneously by a team
composed of a clinical
oncologist, a neuro-
oncologist, a neurosurgeon,
a radiotherapist, and a
nurse, based on the prior
review of imaging and
pathology by a
neuroradiologist and a
neuropathologist. Every
Thursday there are also
multidisciplinary meetings
- Tumor Boards - for
discussion of cases of
tumors of the nervous
system.

The Neuropediatric
oncology service also has a
highly specialized team.

Diagnosis
Neuroimaging 
The neuroimaging service
at Einstein is composed of a
multidisciplinary team that
seeks to deliver the best
quality exams for the
diagnosis, treatment
planning, and follow-up of
patients with tumors of the
central nervous system.
The hospital has modern
equipments of Magnetic
Resonance Imaging (1.5
and 3.0 Tesla) and
Computed Tomography
(CT), as well as hybrid
equipment (PET/CT and
SPECT/CT – and, since
2015, it has PET/MRI), in
order to produce the main
imaging exams used for
these patients:
• Computed Tomography
• Magnetic Resonance
o Conventional Magnetic
Resonance
o Brain Perfusion and
Proton NMR Spectroscopy 
o Functional magnetic
resonance imaging: pre-
intervention brain
mapping 
o Tractography: pre-
intervention brain
mapping 
• Nuclear Medicine /
Molecular Imaging
o Glucose metabolism with
18F-FDG PET/CT  
o Gallium metabolism
PET/CT  
o SPECT/CT cerebral
blood flow 
o (Tc-TRODAT)
dopamine transporter
SPECT/CT
o 18-FDG PET/MR for
glucose metabolism 
o PET/MRI metastases of
prostate CA (GA-PSMA) 
o PET/MR somatostatin
analogues (Ga -
DOTATATE)
    
All tests performed in our
department are stored in
digital format (PACS) at
the hospital’s own servers,
allowing quick access and
retrieval if necessary,
facilitating an evolutive
analysis and comparison
between the different
modalities.
All physicians involved
have specific training in
neuroimaging and, in the
case of hybrid methods, the
interpretation is made
jointly by teams of
neuroradiology and
nuclear medicine, always
with the goal of
maximizing the quality and
reliability of each method.

• CSF  
• Electrophysiological
studies (EEG, evoked
potential, ENMG)
• Neuropathology

The permanent contact of


the clinical-surgical and
neuroradiological teams
with our renowned and
experienced
neuropathologists is a
fundamental element in
reaching an accurate
diagnosis integrated into
the context of molecular
neuro-oncology. 
Integrated Treatment
• Neurosurgery
o Neuronavigation
o Intraoperative
electrophysiological
monitoring 
o Intraoperative
ultrasound
o Stereotaxis 
• Specialized postoperative
monitoring in the
neurological intensive care
unit and neurological
inpatient unit with
neurologists on duty 24
hours
• Einstein Center of
Oncology and Hematology 
o Outpatient and inpatient
chemotherapy units
o Emergency care specific
for oncology patients
o Bone Marrow
Transplant
o Radiotherapy

The Radiotherapy Service


of Einstein offers the most
advanced technologies in
this specialty. These
technologies, coupled with
a philosophy of
multidisciplinary oncology
care, maximize the results
of our treatments. The
following technologies are
our distinctions, our
standard operating
procedure as pioneers in
our country:   
• Conformal
radiotherapy: 1993
• Radiosurgery: 1993
• Fractionated Stereotactic
Radiotherapy: 1994
• IMRT (Intensity-
modulated radiation
therapy): 2001
• SBRT (Extracranial
Radiosurgery): 2007
• Dedicated Computed
Tomography (4-D Imaging
dedicated to radiotherapy):
2008
• RapidArc® (VMAT -
Volumetric modulated arc
therapy): 2010  
 
Objectively, we are in a
position to offer solutions
with maximum efficiency
in all clinical situations that
require radiation therapy.
More than just cutting-
edge technology, our
patients receive warm and
humanized care that makes
a difference in delicate
situations such as in the
treatment of cancer. Our
service is comprehensive
and, in addition to the
highly specialized and
dedicated teams of
physicians, medical
physicists, biomedical
scientists, and technicians,
there is the support from
nurses, nutritionists,
psychologists, and
physiotherapists. All this to
make your experience
through radiotherapy as
easy and successful as
possible.  
• Oncogeriatrics
• Oncogenetics
• Motor and cognitive
rehabilitation
• Palliative Care/
supportive  medicine 
• Integrative Medicine
• Clinical Diet
Clinical research and
basic research
• Information

Pediatric Neurology
Some neurological diseases
are common in childhood
and adolescence:
meningitis, encephalitis,
epilepsy, sleep disorders
(somnambulism, for
example), muscular
diseases, and headaches,
among others.
Neuropediatrics is the
branch of neurology that
studies these and other
diseases of the development
and maturation of the
nervous system. 

Medical Specialties Clinic


Einstein offers special
services in the Medical
Specialties Clinic. The
Clinic offers integrated
care and expertise by a
multiprofessional team:
physicians from different
specialties, nurses,
physiotherapists, speech
therapists, nutritionists,
and psychologists.

This care is provided in


partnership with the
child’s own pediatrician
because we believe that it is
essential to exchange
experiences in striving to
improve treatment.
Einstein also encourages
family participation
throughout the period of
diagnosis and treatment.
Services at the Medical
Specialties Clinic  
- Multidisciplinary
monitoring of Child
Development
- Outpatient follow-up 
- Outpatient appointments 
- Assessment of
Development, Behavior,
and Learning 
- Center for Respiratory
Diseases 
- Childhood Diabetes 
- Enuresis
- Clinical Therapy
Program and Fetal
Surgery 
- Clinical Therapy
- Surgical Therapy
- Integrated Care
- Down Syndrome 
Multiple sclerosis and
Demyelinating Diseases
Multiple sclerosis is a
neurological autoimmune
disease that can cause
motor difficulties, speech
problems, depression, loss
of sensitivity, visual
alterations, and fatigue,
among other things.
According to the most
accepted current medical
theories, the disease is
triggered by a combination
of factors including genetic
predisposition,
environmental aspects, and
viral infections. 
    
Demyelinating diseases are
those in which the myelin
sheath (a substance present
in some cells of the
hypothalamus) of neurons
is damaged.

Multiple Sclerosis Center 


In our Multiple Sclerosis
Center at Einstein, patients
receive complete care
including diagnosis,
treatment, and
monitoring. 

This care includes, among


other things,
recommendation for
auxiliary therapy, a second
opinion for physicians
regarding treatment, early
identification of any
therapeutic failure,
identification of any side
effects, and improved
patient adherence to the
recommended treatment,
in addition to early
identification of any
possible serious
complications arising from
immunosuppressant
treatments.

All patients in the hospital


who have the disease can
be treated by the center,
provided that the
physicians responsible
deem it necessary. The
professional team is
multidisciplinary, made up
of neurologists, urologists,
physiatrists,
ophthalmologists,
neuroradiologists, and
other specialties. The
group also includes:
nurses, pharmacists,
physiotherapists, speech
therapists, psychologists,
and nutritionists, among
others.

The treatment of multiple


sclerosis provides the
following protocols:
A.Corticosteroid
pulsotherapy;
B.Bone marrow transplant
- specific cases;
C.Treatment with
natalizumab;
D.Treatment with
rituximab;
E.Treatment with
alemtuzumab;
F. Immunosuppressive
therapy with
cyclophosphamide;
G. Immunosuppressive
therapy with
mitoxantrone;
H. Treatment with
immunoglobulins;
I. Treatment with
fingolimod - oral;
J. Treatment with
plasmapheresis
Epilepsy
What it is
Epilepsy is a common
neurological condition
affecting approximately
one in every 100 people.
The disease is
characterized by the
occurrence of epileptic
seizures that repeat at
varying intervals. These
seizures are the clinical
manifestations of an
abnormal discharge of
neurons, which are the cells
that make up the brain.

Causes
The disease may have
several causes that vary
according with the type of
epilepsy and with the age of
the patient. In children, for
example, neonatal anoxia
(lack of oxygen in the brain
during childbirth) and
inborn errors of
metabolism (metabolic
alterations that have
existed since birth) are
frequent causes of epilepsy.
In the elderly, on the other
hand, cerebrovascular
disease (stroke), as well as
brain tumors, are some of
the most frequent causes.
Signs and Symptoms
There are several types of
epileptic seizures, each
with different
characteristics. One of the
most common types is the
generalized tonic-clonic
seizure, usually simply
called "seizure." This type
of episode is easily
recognizable because the
patient presents
generalized muscle spasms,
sialorrhea (excessive
salivation), and often bites
his tongue and loses urine
and feces.  

Other seizures, however,


may not be recognized by
patients, their relatives, or
even by doctors because
they have subtle
manifestations, such as a
slight change in behavior, a
fixed gaze, or automatic
movements.

In children, for example,


the occurrence of absence
seizures is common,
characterized by a brief
stop in the child’s activity,
sometimes associated with
eyes blinking or automatic
movements of the hands.
These absence seizures may
occur many times a day. In
some cases they are not
readily recognized, and
only when the child begins
to show a decline in school
performance – usually
pointed out by a teacher –
is this possibility
considered. 
Diagnosis
This is done by evaluating
the patient's history, with
information on the types of
seizures presented, the age
of onset of symptoms, and
family history, among
other things.
Supplementary exams are
important to assist in the
diagnosis, such as an
electroencephalogram, a
brain computerized
tomography (CT) scan, and
an magnetic resonance
imaging (MRI) of the
brain. The proper
diagnosis of epilepsy and
the type of seizures
presented by the patient
help determine the
appropriate treatment.

Treatment
Epileptic seizures are
treated with the use of
specific medications, called
antiepileptic drugs. There
are more than 20 drugs
currently available for the
treatment of epilepsy—not
all are sold in Brazil.
With the clinical treatment
(with anti-epileptic drugs),
about two-thirds of
patients have their seizures
controlled. A significant
number – about a third –
continue having seizures in
spite of the clinical
treatment.

For these patients, other


treatment options may be
considered, such as the use
of a ketogenic diet (similar
to the Atkins diet),
especially in children, and
surgical treatment. Other
forms of treatment, such as
methods of
neurostimulation and the
use of stem cells, are still
being studied.

It is important to highlight
that the majority of people
with epilepsy have their
seizures controlled with
pharmacological treatment
and therefore may have a
normal life with little or no
limitation. The recognition
of the episodes and the
correct diagnosis allow the
best treatment to be started
early so that the patient
may resume his or her
normal activities.

Prevention
Some causes of epilepsy
such as neonatal anoxia or
cerebrovascular disease
can be prevented. Thus,
proper prenatal care and
good labor care can
certainly help to reduce the
number of cases of epilepsy
related to childbirth
problems.
In the same way, suitable
control of risk factors for
cerebrovascular diseases
such as hypertension and
diabetes can help reduce
the number of strokes,
thereby reducing the cases
of epilepsy caused by this
disease.
Neuromuscular Diseases
Neuromuscular diseases
(diseases of motor neurons,
the cervical plexus, and the
lumbosacral spine) affect
the peripheral nervous
system, which is composed
of muscles, peripheral
nerves, and neuromuscular
junctions.  
 
The most common are:
diabetic neuropathy as well
as other peripheral
neuropathies and
myopathies (muscle
diseases), myasthenia
gravis, and amyotrophic
lateral sclerosis (ALS).

Treatment
The Hospital Israelita
Albert Einstein has a team
of physicians specialized in
the neuromuscular area
and a cutting-edge
infrastructure to perform
all the laboratory tests that
are important for
diagnosing these diseases.
Rehabilitation is also an
advantage offered by the
hospital, which has a
multidisciplinary
rehabilitation team
specializing in
neuromuscular diseases.
 
Sleep Disorders
The required amount of
hours of sleep varies
according to age. However,
frequent symptoms such as
persistent fatigue,
irritability, lack of
attention and a drop in
productivity should be
observed carefully - they
may be signs of sleep
disorders. In more severe
cases, patients may even
present cardiovascular
disease and depression.
The medical world
recognizes three main
groups of sleep disorders:
- insomnia
- excessive sleepiness
- abnormal behaviors
during sleep
Sleep is a natural
behavioral state and is
essential for the proper
balance and functioning of
all our organs and systems.
Sleep disorders, then, are
those conditions that
interfere with this balance
and have a consequent
impact on our health and
quality of life.
There is increasing
scientific evidence of the
impact of sleep disorders
on cardiovascular diseases
(cases of coronary artery
disease, arrhythmias, and
hypertension), metabolic
and endocrine disorders
(such as obesity and
growth alterations),
neurological diseases (pain,
cognitive changes, epilepsy,
attention deficit, and
stroke), gastrointestinal
diseases (cases of reflux),
psychiatric disorders
(bipolar affective disorder,
depression, and anxiety),
and urological diseases
(nocturia), among others.
The evolution of knowledge
in this area has raised
Sleep Medicine to the
status of a field of study in
Brazil, which comprises a
wide interface between
internal medicine (and its
various specialties) and
neuroscience. Nowadays in
Brazil, there are certified
specialists in Sleep
Medicine.
Symptoms
Sleep disorders vary from
extremely benign and
common, such as
temporary difficulty in
getting a good night's sleep
before situations of
excessive stress (acute
insomnia), to more
complex situations such as
severe sleep apnea with
cardiovascular and
metabolic impact, among
other things. 
The main symptoms
related to sleep disorders
are excessive sleepiness or
fatigue during the day
and/or excessive
wakefulness or alertness at
night. 
Other abnormal
manifestations involve
atypical behaviors during
the sleep period such as
parasomnias (sleepwalking,
confusional arousal, and
night terrors) or other
abnormal behaviors during
or close to sleep time. In
addition, sleep disorders
should always be
considered as aggravating
factors in situations of
illnesses of another nature.
Diagnosis
In addition to observations
from relatives of our
behavior as we sleep, there
is polysomnography, which
analyzes the patient while
he or she sleeps.
A night of sleep monitored
by electrodes and sensors
in a specialized laboratory
is the way to see what the
problem is. The test
monitors the movements of
the eyes and legs, the
electrical activity of the
brain, the breathing, and
the blood oxygen content,
among other things.
Einstein has a clinical staff
with certified specialists in
Sleep Medicine and two
modern polysomnography
laboratories (Morumbi and
Vila Mariana Units), in
addition to offering
polysomnography at home.
In addition, there is an
infrastructure of skilled
professionals, as well as an
advanced diagnostic center
where the
polysomnography tests are
applied. 
Alzheimer's disease and
other dementias
Alzheimer's is a
degenerative disease whose
main symptom is the loss of
memory. This condition
affects the brain functions,
which can cause time
confusion and personality
changes. This impairs
everyday activities such as
going to work or keeping in
touch with relatives and
friends. At a more
advanced stage, patients
face physical limitations in
the ability to walk and even
to swallow.

Center of Excellence in
Memory
At Einstein, Alzheimer's
and other diseases related
to memory are treated at
the Center of Excellence in
Memory (NEMO). This
Center was created in
order to provide
professional care for a
growing demand. In Brazil,
healthcare experts estimate
that approximately 1
million people suffer from
the disease.
NEMO has a team of
highly specialized
professionals who, through
high technology techniques,
seek the earliest possible
diagnosis of the disease and
the appropriate treatment
to ensure a better quality of
life for patients and their
families.
Contact: +55 (11) 2151-
1100 (Call Center –
Rehabilitation)
Business Hours: 
From 7 AM to 7 PM,
Monday through Saturday
– except on Wednesdays –
from 12 to 4 PM
Location: Medical Office
307, 3rd Floor, Wing A1

Services offered by
NEMO: 
1. Computerized Memory
Evaluation
Clinical evaluation with a
neurologist done by means
of a computerized test that
assists in the diagnosis of
memory disorders and
dementia. This tool
evaluates executive
function and mental
control, language / symbol
fluency, and memory.
Created in the United
States and subsequently
adapted and validated for
Brazil, the test is done on
instruments with a touch
screen. This makes it easier
for people who are not
accustomed to using
computers.
2. Clinical evaluation with
a specialized doctor
Medical consultation with a
specialized neurologist 
To schedule a visit:     
Morumbi Unit: Call Center
– Rehabilitation: +55 (11)
2151-1100, from 7 AM to 7
PM Monday through
Saturday. 
For more information,
please call +55 (11) 2151-
5094 or +55 (11) 2151-3555
from Monday to Friday, 8
AM to 6 PM BRT (Brasília
Time) 
Or contact us by e-mail:
Neuro-.einstein@einstein.b
r.
3. Tap Test - Evaluation of
suspected Normal Pressure
Hydrocephalus (NPH)
This is a multidisciplinary
test to check for normal
pressure hydrocephalus
syndrome, in which the
patient presents gait
alterations, dementia, and
urinary incontinence,
which is one of the causes
of dementia. With proper
diagnosis, the disease can
be treated and reversed,
even if only partially.
The Tap Test is conducted
in more than one stage:
1. Neuropsychological
Assessment and Gait
Evaluation at the Gait
Laboratory (LEME) of the
Hospital Albert Einstein 
At the laboratory, the
gait/walk is analyzed by
means of a 3-dimensional
analysis system of the
movement, made up of ten
infrared cameras, two
force platforms, and a
dynamic surface
electromyography (EMG)
apparatus. 
2. Collection of
Cerebrospinal Fluid and
Neuropsychological and
Gait Reassessment at the
LEME facilities    

After the batteries of tests,


a comparison is made and
a report generated, which
is then forwarded to the
responsible physician.
To schedule the test:

You might also like